SCHEMBL7870566

SCHEMBL7870566

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCO)nc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.43
CA2 P00918 2/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP2C9 P11712 2/20 0.42
LMNA P02545 1/20 0.42
ALB P02768 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
P4HTM Q9NXG6 3/20 0.41
SMPD1 P17405 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
GABRA5 P31644 2/20 0.39
KDM4E B2RXH2 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867792 0.96 CA2 (0.49) EGFRCA2P4HTMSMPD1CA12
SCHEMBL7869442 0.91 EGFR (0.43) EGFRCA2ALDH1A1CYP2C9LMNA
SCHEMBL7871681 0.91 EGFR (0.46) EGFRCA2P4HTMCA12CA1
SCHEMBL7870463 0.91 KMT2A (0.46) EGFRALDH1A1LMNAP4HTMKDM4E
SCHEMBL7871651 0.90 BCL2L1 (0.46) EGFRLMNAP4HTMKMT2ATP53
SCHEMBL7867848 0.90 SMN1; SMN2 (0.45) ALDH1A1LMNAP4HTMSMPD1GABRA5
SCHEMBL7867827 0.90 KMT2A (0.42) EGFRCA2ALDH1A1CYP2C9LMNA
SCHEMBL9574879 0.90 NPC1 (0.52) CA2ALDH1A1CA12CA1CA9
SCHEMBL7874534 0.89 EGFR (0.42) EGFRCA2ALDH1A1LMNAP4HTM
SCHEMBL7862801 0.88 CA2 (0.48) EGFRCA2ALDH1A1P4HTMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed